Victory Capital Management Inc. Sells 74,823 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Victory Capital Management Inc. decreased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 21.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 269,774 shares of the company’s stock after selling 74,823 shares during the period. Victory Capital Management Inc. owned 0.29% of Acadia Healthcare worth $20,978,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in ACHC. Headlands Technologies LLC bought a new stake in shares of Acadia Healthcare during the 3rd quarter valued at $25,000. GAMMA Investing LLC bought a new stake in Acadia Healthcare during the fourth quarter valued at about $26,000. Fifth Third Bancorp lifted its position in shares of Acadia Healthcare by 25.5% in the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after acquiring an additional 136 shares in the last quarter. DekaBank Deutsche Girozentrale bought a new position in shares of Acadia Healthcare in the third quarter worth about $96,000. Finally, Oak Thistle LLC purchased a new stake in shares of Acadia Healthcare during the fourth quarter worth about $235,000.

Acadia Healthcare Price Performance

NASDAQ:ACHC opened at $70.49 on Friday. The firm has a market capitalization of $6.54 billion, a price-to-earnings ratio of -503.50, a PEG ratio of 1.96 and a beta of 1.31. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 1.27. The business has a 50 day simple moving average of $75.41 and a 200-day simple moving average of $77.27. Acadia Healthcare Company, Inc. has a 1 year low of $64.74 and a 1 year high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Thursday, May 2nd. The company reported $0.84 EPS for the quarter, topping the consensus estimate of $0.80 by $0.04. The company had revenue of $768.10 million during the quarter, compared to analyst estimates of $779.20 million. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. Acadia Healthcare’s quarterly revenue was up 9.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.75 earnings per share. Equities analysts forecast that Acadia Healthcare Company, Inc. will post 3.56 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have weighed in on ACHC shares. TD Cowen upped their price target on Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a research note on Friday, March 1st. Royal Bank of Canada reaffirmed an “outperform” rating and set a $94.00 target price on shares of Acadia Healthcare in a research note on Monday, March 4th. TheStreet upgraded shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research note on Monday, March 4th. Bank of America cut their price objective on Acadia Healthcare from $105.00 to $90.00 and set a “buy” rating for the company in a research report on Thursday, May 2nd. Finally, Mizuho decreased their target price on Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating on the stock in a research report on Friday, May 3rd. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $88.89.

Insider Transactions at Acadia Healthcare

In related news, Director Wade D. Miquelon sold 2,203 shares of the stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 2.00% of the company’s stock.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.